Adman Formulation Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.40 M
- Company Age 29 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.48 Cr
- Revenue Growth 22.30%
- Profit Growth -16.27%
- Ebitda -9.09%
- Net Worth 4.15%
- Total Assets 3.02%
About Adman Formulation
Adman Formulation Pvt Ltd (AFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 December 1995 and has a history of 29 years and one month. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.40 M.
The company currently has active open charges totaling ₹4.48 Cr.
Manoj Sinha and Kiran Sharma serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232MP1995PTC010276
-
Company No.
010276
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Dec 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Adman Formulation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Sinha
|
Director | 20-Dec-1995 | Current |
|
Kiran Sharma
|
Director | 19-Apr-2021 | Current |
Financial Performance of Adman Formulation.
Adman Formulation Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 22.3% increase. The company also saw a substantial fall in profitability, with a 16.27% decrease in profit. The company's net worth moved up by a moderate rise of 4.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adman Formulation?
Unlock access to Adman Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Blueheavens Lifecare Private LimitedManoj Sinha is a mutual person
-
Amco Herbals Private Limited
Kiran Sharma is a mutual person
Charges (Loans)
₹44.81 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.20 Cr
- Hdfc Bank Limited : 2.12 Cr
- State Bank Of Indore : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Sep 2023 | Hdfc Bank Limited | ₹1.30 M | Open |
| 20 Feb 2023 | Hdfc Bank Limited | ₹1.99 Cr | Open |
| 26 Sep 2006 | State Bank Of India | ₹2.20 Cr | Open |
| 26 Apr 2000 | State Bank Of Indore | ₹0.60 M | Open |
| 15 Oct 1997 | State Bank Of Indore | ₹0.50 M | Open |
How Many Employees Work at Adman Formulation?
Unlock and access historical data on people associated with Adman Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adman Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adman Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
